No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Cholbam is a market of drugs used to treat liver and kidney disorders. It is composed of medications that are used to treat a variety of conditions, including hepatitis, cirrhosis, and kidney failure. These drugs are used to reduce inflammation, improve liver and kidney function, and reduce the risk of complications. Cholbam is a combination of two drugs, cholic acid and bile acid, which are used to treat a variety of liver and kidney disorders. The drugs are available in both oral and injectable forms.
Cholbam is a relatively new market, but it is growing rapidly. It is becoming increasingly popular as a treatment option for liver and kidney disorders due to its effectiveness and safety.
Companies in the Cholbam market include AbbVie, Allergan, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more
